Gabapentin Market

Gabapentin Market Size, Share, Growth Analysis, By Dosage Form(Tablet, Capsule, Oral Solution), By Type(Generic, Branded), By Application(Epilepsy, Neuropathic Pain, Restless Legs Syndrome, Others), By Distribution Channel(Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Regional(North America, Europe, Asia Pacific, Latin America) - Industry Forecast 2024-2031


Report ID: UCMIG35I2148 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Gabapentin Market Insights

Market Overview:

The global gabapentin market experienced significant growth in 2022, with an estimated size of USD 2,022.84 million. Looking ahead, the market is projected to witness a compound annual growth rate (CAGR) of 5.35% from 2023 to 2030. This growth can be attributed to several factors, including the rising prevalence of neurological disorders such as epilepsy and neuropathic pain, which are commonly treated with gabapentin. Additionally, the increasing geriatric population and the expanding use of gabapentin in off-label indications contribute to the market's expansion. As a result, the gabapentin market is anticipated to offer lucrative opportunities for pharmaceutical companies and Health Care providers in the coming years.

Gabapentin Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Pharmaceuticals by segment aggregation, the contribution of the Pharmaceuticals in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Gabapentin was estimated to be valued at US$ XX Mn in 2021.

The Gabapentin Market is estimated to grow at a CAGR of XX% by 2028.

The Gabapentin Market is segmented on the basis of Dosage Form, Type, Application, Distribution Channel, Regional.

Based on region, the Gabapentin Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Gabapentin Market are Zydus Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Ascend Laboratories, LLC, Apotex Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma., Amneal Pharmaceuticals LLC., Cipla USA, Inc., BP Pharmaceuticals Laboratories Company, Assertio Holdings, Inc., Arbor Pharmaceuticals, Inc., Pfizer Inc..

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Gabapentin Market

Report ID: UCMIG35I2148

$5,300
BUY NOW GET FREE SAMPLE